/PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of Aligos Therapeutics, Inc. ("Aligos" or the "Company") (NASDAQ: ALGS). Such.
/PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of Aligos Therapeutics, Inc. ("Aligos" or the "Company") (NASDAQ: ALGS). Such.
/PRNewswire/ Vipergen, a leading provider of small-molecule drug discovery services based on DNA-encoded library (DEL) technologies, announced today the.